help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 21, 2005
Endocrinology, doi:10.1210/en.2004-1675
A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/7/3044    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renström, F.
Right arrow Articles by Eriksson, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renström, F.
Right arrow Articles by Eriksson, J. W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
*GLUCOSE

Submitted on December 29, 2004
Accepted on April 7, 2005

Insulin receptor substrates 1 and 2 are both depleted but via different mechanisms in rat adipocytes following down-regulation of glucose transport

Frida Renström, Jonas Burén, and Jan W. Eriksson*

Department of Public Health and Clinical Medicine, Medicine, Umeå University Hospital, Umeå, Sweden

* To whom correspondence should be addressed. E-mail: jan.eriksson{at}medicin.umu.se.

Alterations in muscle and adipose tissue insulin receptor substrate 1 (IRS-1) and IRS-2 are associated with, and commonly believed to contribute to, development of insulin resistance. In this study, we investigated the mechanisms behind previously observed reductions in IRS levels due to high concentrations of glucose and insulin, and their significance in the impairment of glucose uptake capacity in primary rat adipocytes. Semi-quantitative RT-PCR analysis showed that insulin (1000 µU/mL) alone or in combination with glucose (15 mM) markedly suppressed IRS-2 gene expression, whereas IRS-1 was unaffected by the culture conditions. The negative effect of a high glucose/high insulin setting on IRS-1 protein level was still present when protein synthesis was inhibited with cycloheximide. Impairment of glucose uptake capacity following treatment with high glucose and insulin was most pronounced after 3 h, whereas IRS-1 and IRS-2 protein levels were unaffected up to 6 h but were reduced after 16 h. Moreover, impaired glucose uptake capacity could only partially be reversed by subsequent incubation at physiological conditions. These novel results suggest that: (i) In a high glucose/high insulin setting depletion of IRS-1 and IRS-2 protein, respectively, occurs via different mechanisms, IRS-2 gene expression is suppressed whereas IRS-1 depletion is due to post-translational mechanisms. (ii) IRS-1 and IRS-2 protein depletion is a secondary event in the development of insulin resistance in this model of hyperglycemia/hyperinsulinemia. (iii) Depletion of cellular IRS in adipose tissue may be a consequence rather than a cause of insulin resistance and hyperinsulinemia in type 2 diabetes.


Key words: glucose transport • insulin signaling • fat cells • gene expression • insulin resistance







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society